Redwire
Integrated aerospace and defense company combining in-space additive manufacturing and space infrastructure with combat-proven unmanned aerial systems (following its 2025 Edge Autonomy acquisition) and in-space pharmaceutical development via its SpaceMD division.
- CEO / Founder
- Peter Cannito
- Team Size
- 1001-5000
- Stage
- Public
- Total Funding
- Publicly Traded
- Latest Round
- Post-IPO
- Key Investors
- AE Industrial Partners; Genesis Park Acquisition Corp
Technology & Products
Key Products
Redwire develops in-space additive manufacturing systems, power generation (IROSA solar arrays), antennas, deployable solutions, star trackers, and other spacecraft components. Following its 2025 acquisition of Edge Autonomy, Redwire now also produces combat-proven unmanned aerial systems (UAS) including the Stalker and Penguin platforms under its Defense Tech segment, and its SpaceMD division develops pharmaceuticals via in-space drug development. The company also offers digital engineering and AI automation for aerospace infrastructure and autonomous systems.
Technological Advantage
Proprietary microgravity 3D printing processes validated on the International Space Station, protected by over 300 active patents covering space-based algorithms and hardware.
Differentiation
Value Proposition
Delivers mission-critical space and defense technology: reduces space mission costs via in-space manufacturing of spare parts/components (cutting lead times from months to days), while its Defense Tech segment (from the 2025 Edge Autonomy acquisition) supplies combat-proven UAS platforms and its SpaceMD division develops in-space pharmaceuticals.
How They Differentiate
3x more flight heritage than new-space AM startups with proven ISS deployments, offering end-to-end in-space manufacturing vs. Earth-based only competitors.
Market & Competition
Target Customers
NASA, Department of Defense, commercial space companies, pharmaceutical firms
Industry Verticals
Aerospace; Defense; Medical; Research
Competitors
Relativity Space; Sierra Space; Stratasys
Growth & Milestones
Growth Metrics
Revenue grew 24.73% YoY to $304.1M in 2024; forecast $450M-$500M for 2026.
Major Milestones
First 3D printer on ISS (2014); Acquisition of Made in Space (2020); Public listing via SPAC (2021); 3D bioprinting of live human heart tissue on ISS (2024); Acquisition of Edge Autonomy for $925M, creating multi-domain space and defense tech company (June 2025); Retired Edge Autonomy brand, reorganized into Space and Defense Tech segments (January 2026); Record Q2 2026 revenue of $117.1M, up 89.6% YoY (August 2026)
Notable Customers
NASA; Department of Defense; Commercial space entities; Axiom Space (October 5, 2026 follow-on contract for two ROSA wings for Axiom Station's second module)
AM patents
AM-relevant patents linked to this company.
- Patents
- 1
- Granted
- 0
- Families
- 1
Leading domains: equipment (1), process (1)
Filings by year: 2025: 1
- BIOMANUFACTURING SYSTEM, METHOD, AND 3D BIOPRINTING HARDWARE IN A REDUCED GRAVITY ENVIRONMENT20250230391 · US
Funding rounds
- Post-IPO$500M ATM equity program (>$530M raised H1 2026)2026-06Source: stocktitan.net / theglobeandmail.com - Redwire establishes expanded at-the-market equity program, June 9 2026
- IPOUndisclosed2021-09Source: Redwire Press Release - September 2021
- Strategic InvestmentUndisclosed2020-06Source: Redwire Press Release - June 2020